Noll Laboratory
University Park, Pennsylvania, 16802, United States
NCT Number: NCT06444594
Neurovascular signaling in the skin associated with stimulation of the transient receptor potential (TRP) channels. These channels are stimulated by both temperature and naturally occurring bioactive agents found in mint, chili peppers, garlic, etc. The aim of the study is to examine how topically applied TRP channel agonists including menthol, capsaicin and camphor impact neurovascular responses in the skin.
Interested in participating?
Request Info18 year–85 year
All sexes
Interventional
Early Phase 1
University Park, Pennsylvania, 16802, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
menthol gel 4-10%
Other names: menthol
camphor gel 5-20%
Other names: camphor
capsaicin gel 0.05-1%%
Other names: capsaicin
menthol (4-10%), capsaicin (0.05-1%), camphor (5-20%)
Other names: menthol, capsaicin, camphor
Inactive vehicle gel
Other names: Inactive vehicle gel
Time frame: 75 minutes
Laser doppler flowmeter to measure skin blood flow during a slow local heating of the skin
Time frame: every 5 minutes for 120 minues
heat and cold perception using a visual analog scale
Time frame: every 30 minutes for 120 minutes
pain pressure thresholds
Penn State University
Other
Transient Receptor Potential Channels in Human Skin
Acronym: TRP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06856720
Aging, Diabetes Mellitus
Viseu, Viseu District, Portugal
View Trial DetailsNCT05973448
Aging, Alzheimer Disease
Chapel Hill, North Carolina, United States
View Trial DetailsNCT05307666
Adverse Drug Interaction, Aging
Edmonton, Alberta, Canada
View Trial DetailsNCT07298876
Aging, Central Nervous System Diseases
Hong Kong, Tai Po District
View Trial Details